Ignite Creation Date:
2025-12-24 @ 5:45 PM
Ignite Modification Date:
2026-02-04 @ 12:46 AM
Study NCT ID:
NCT04681768
Status:
COMPLETED
Last Update Posted:
2025-09-26
First Post:
2020-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients
Sponsor:
Technical University of Munich
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer/ Metastatic Breast Cancer | View |
Keywords: